Canadian Movement Disorders Society (CMDS) Congress 2026

The 2026 Canadian Movement Disorders Society (CMDS) Congress is where our community convenes to shape the future of care, research, and collaboration.

This national meeting brings clinicians, scientists, allied health professionals, and trainees together to engage with the latest clinical advances and research changing the landscape of movement disorders care and treatment in Canada. Programming will highlight emergent therapies and clinical trials, new technologies, strategies for improving access to care, and much more.

Specific to the Canadian health care context, community members will also engage in discussion about the development of national guidelines for Parkinson’s disease, dystonia, and ataxia. We will also explore how we can work together to establish a Canadian clinical trials network for movement disorders.

Target Audience

Health care professionals and researchers involved in movement disorders care and research. The 2026 CMDS Congress welcomes participation from:

• Neurologists, neurosurgeons, psychiatrists, geriatricians, and other physicians
• Clinical researchers and fundamental/translational scientists
• Nurses, physical therapists, speech-language pathologists, psychologists, and other allied health professionals
• Fellows, residents, graduate students, and other trainees